RxDoctor Payments Data

Ryan Jones, MD

Colon & Rectal Surgery · Louisville, KYNPI 1770921801

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Medtronic at 58.3% of the total. Reporting peaked in 2021 at $2,398 and has fallen 95.1% since, to $117 in 2025.

$6,548in general payments, 2019–2025

Across 49 payments — averaging $133.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Intuitive Surgical$2K
  • Baxter Healthcare$846
  • Innovation Technologies Inc$91
  • Merck$59
  • AbbVie$34

What the payments were for

  • Consulting fees$3,15048%
  • Travel & lodging$3806%
  • Food & beverage$2,01831%
  • Education$1,00015%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic24$3,819
Intuitive Surgical7$1,699
Baxter Healthcare10$846
Innovation Technologies Inc1$91
Merck5$59
AbbVie(2 entities)2$34

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,548 in reported general payments places this provider in the 60th percentile of 28 colon & rectal surgery providers in Kentucky.

See all colon & rectal surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$91,338
Medicare patients
172
Services billed
367

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin Sulfate49$267
Oxycodone Hcl36$138
Metronidazole48$60

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →